Overview of Libbera D
Libbera D is a combination pharmaceutical preparation intended for systemic, oral use, which simultaneously addresses allergic symptoms and nasal congestion. It is classified as an antihistamine and a nasal decongestant (sympathomimetic) combination product, typically manufactured as a tablet or oral solution.
| Property | Description |
|---|---|
| Active Ingredients | Levocetirizine, Pseudoephedrine |
| Form | Capsule, Tablet, Oral Solution |
| Pharmacological Class | Antihistamine and Sympathomimetic |
| Common Use | Relief from Allergic Rhinitis and Congestion |
| Origin | Synthetic |
What Type of Medicine is Libbera D?
Libbera D is a fixed-dose combination product that merges two active, synthetically derived ingredients, Levocetirizine and Pseudoephedrine, to provide a specialized dual therapeutic effect. This product is generally available in markets where the specific formulation is approved, such as those served by manufacturer Laboratorio Hersil. The medication's classification combines a selective histamine H1-receptor antagonist with a potent sympathomimetic agent. This design is intended for managing both the internal allergic reaction and the associated physical congestion concurrently.
Composition: Levocetirizine and Pseudoephedrine
The core composition includes the two distinct active ingredients. Levocetirizine is the antihistamine component, known as the pharmacologically active enantiomer of Cetirizine, which acts by blocking the effects of histamine released during an allergic reaction. Pseudoephedrine functions as the decongestant, working through vasoconstriction—the narrowing of blood vessels in the nasal lining—to reduce swelling and congestion. As the active enantiomer of Cetirizine, Levocetirizine is utilized in managing allergic symptoms such as sneezing and itching, while the antihistamine component works to reduce the primary discomfort of allergy flare-ups.
General Purpose and Relief
The general purpose of Libbera D is to provide comprehensive relief for symptoms commonly associated with conditions like allergic rhinitis or hay fever, especially when these are complicated by significant nasal congestion. This medication is designed to target both the fluid production from allergies and the tissue swelling of congestion. By combining the histamine-blocking action of Levocetirizine with the decongesting effect of Pseudoephedrine, the preparation aims to alleviate multiple, often co-occurring, symptoms, including sneezing, itching, a runny nose, and the discomfort of sinus pressure.
Regulatory References
